Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 50029712
Affinity DataKi: 260nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activityMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 2.40E+3nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+4nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+4nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+4nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 3.60E+4nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 3.80E+4nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 5.90E+4nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair
Affinity DataIC50: 6.60E+4nMAssay Description:Compound was evaluated for inhibition of human alpha-thrombin catalytic activity.More data for this Ligand-Target Pair










